Published in Am J Psychiatry on February 01, 1997
Psychiatric comorbidities and schizophrenia. Schizophr Bull (2008) 2.69
How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull (2009) 1.69
Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia: is there evidence for a schizo-obsessive subtype of schizophrenia? J Psychiatry Neurosci (2005) 1.49
Diagnosis and treatment of a patient with both psychotic and obsessive-compulsive symptoms. Am J Psychiatry (2010) 1.46
Obsessive-compulsive disorder in schizophrenia: epidemiologic and biologic overlap. J Psychiatry Neurosci (1999) 1.17
Obsessive compulsive symptoms in the psychosis prodrome: correlates of clinical and functional outcome. Schizophr Res (2008) 0.96
Obsessive-compulsive disorder and its related disorders: a reappraisal of obsessive-compulsive spectrum concepts. Dialogues Clin Neurosci (2010) 0.96
Obsessive-Compulsive Disorder, Psychosis, and Bipolarity: A Longitudinal Cohort and Multigenerational Family Study. Schizophr Bull (2014) 0.94
Evidence for inhibitory deficits in the prefrontal cortex in schizophrenia. Brain (2014) 0.86
Obsessive-compulsive disorder comorbidity: clinical assessment and therapeutic implications. Front Psychiatry (2011) 0.86
Neuroanatomical, neurochemical, and neurodevelopmental basis of obsessive-compulsive symptoms in schizophrenia. Indian J Psychol Med (2009) 0.85
Opposite roles of dopamine and orexin in quinpirole-induced excessive drinking: a rat model of psychotic polydipsia. Psychopharmacology (Berl) (2010) 0.82
Interventions for obsessive compulsive symptoms in people with schizophrenia. Cochrane Database Syst Rev (2005) 0.78
A new nosology of psychosis and the pharmacological basis of affective and negative symptom dimensions in schizophrenia. Ment Illn (2010) 0.78
Obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry (1997) 0.75
Drug Induced Obsessive Compulsive Disorder in Schizophrenia. Med J Armed Forces India (2011) 0.75
The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry (1989) 16.61
The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry (1989) 6.80
The National Birth Defects Prevention Study. Public Health Rep (2001) 5.50
A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale. Psychopharmacol Bull (1997) 3.84
The Brown Assessment of Beliefs Scale: reliability and validity. Am J Psychiatry (1998) 3.26
Genetic disease in offspring of long-term survivors of childhood and adolescent cancer. Am J Hum Genet (1998) 2.74
Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience. Mol Psychiatry (2008) 2.55
Evidence for linkage disequilibrium between the alpha 7-nicotinic receptor gene (CHRNA7) locus and schizophrenia in Azorean families. Am J Med Genet (2001) 2.48
Genomewide linkage analysis of bipolar disorder by use of a high-density single-nucleotide-polymorphism (SNP) genotyping assay: a comparison with microsatellite marker assays and finding of significant linkage to chromosome 6q22. Am J Hum Genet (2004) 2.41
Assisted reproductive technology and major structural birth defects in the United States. Hum Reprod (2008) 2.38
Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry (2008) 2.07
DSM-IV field trial: obsessive-compulsive disorder. Am J Psychiatry (1995) 1.93
Symptoms of obsessive-compulsive disorder. Am J Psychiatry (1997) 1.88
Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo. Arch Gen Psychiatry (1989) 1.66
Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry (2012) 1.57
Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine. Arch Gen Psychiatry (1990) 1.56
Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results. Arch Gen Psychiatry (1990) 1.46
Moclobemide in social phobia: a controlled dose-response trial. J Clin Psychopharmacol (1997) 1.46
Support for involvement of neuregulin 1 in schizophrenia pathophysiology. Mol Psychiatry (2005) 1.44
Patterns of remission and relapse in obsessive-compulsive disorder: a 2-year prospective study. J Clin Psychiatry (1999) 1.43
Clinical characteristics and family history in DSM-III obsessive-compulsive disorder. Am J Psychiatry (1986) 1.38
Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia. Mol Psychiatry (2005) 1.34
Tic-related vs. non-tic-related obsessive compulsive disorder. Anxiety (1997) 1.31
Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1). Neurology (2002) 1.25
Is obsessive-compulsive disorder an anxiety disorder, and what, if any, are spectrum conditions? A family study perspective. Psychol Med (2011) 1.25
Genomewide linkage scan for obsessive-compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol Psychiatry (2006) 1.24
Genome-wide scan in Portuguese Island families identifies 5q31-5q35 as a susceptibility locus for schizophrenia and psychosis. Mol Psychiatry (2004) 1.24
Sapap3 and pathological grooming in humans: Results from the OCD collaborative genetics study. Am J Med Genet B Neuropsychiatr Genet (2009) 1.21
Use of clomiphene citrate and birth defects, National Birth Defects Prevention Study, 1997-2005. Hum Reprod (2010) 1.15
Insight and treatment outcome in obsessive-compulsive disorder. Compr Psychiatry (2001) 1.10
Genome-wide scan in Portuguese Island families implicates multiple loci in bipolar disorder: fine mapping adds support on chromosomes 6 and 11. Am J Med Genet B Neuropsychiatr Genet (2004) 1.10
Obsessive compulsive disorder with psychotic features. J Clin Psychiatry (1993) 1.09
Segregation analysis of obsessive-compulsive disorder using symptom-based factor scores. Am J Med Genet (1999) 1.05
A family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder in 378 families. Am J Med Genet B Neuropsychiatr Genet (2009) 1.03
NF1 mutation analysis using a combined heteroduplex/SSCP approach. Hum Mutat (1997) 1.00
Somatic mosaicism in a patient with neurofibromatosis type 1. Am J Hum Genet (1996) 1.00
GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia. Mol Psychiatry (2010) 1.00
Delusionality and response to open-label fluvoxamine in body dysmorphic disorder. J Clin Psychiatry (2001) 0.98
Obsessive-compulsive disorder: subclassification based on co-morbidity. Psychol Med (2008) 0.97
Culture of cytogenetically abnormal schwann cells from benign and malignant NF1 tumors. Genes Chromosomes Cancer (2000) 0.95
Identification of candidate genes for psychosis in rat models, and possible association between schizophrenia and the 14-3-3eta gene. Mol Psychiatry (2003) 0.94
Neurosurgical treatment for refractory obsessive-compulsive disorder: implications for understanding frontal lobe function. J Neuropsychiatry Clin Neurosci (1994) 0.94
Comorbidity of obsessive-compulsive and psychotic symptoms: a review. Harv Rev Psychiatry (1997) 0.93
Gluteus maximus muscle function and the origin of hominid bipedality. Am J Phys Anthropol (1988) 0.92
Association of SLC6A4 variants with obsessive-compulsive disorder in a large multicenter US family study. Mol Psychiatry (2009) 0.92
A new hereditary cylindromatosis family associated with CYLD1 on chromosome 16. Hum Genet (1999) 0.92
Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects. Arch Gen Psychiatry (1988) 0.90
The epidemiology of obsessive compulsive disorder. J Clin Psychiatry (1984) 0.90
Histochemical and physiological properties of cat motor units after self-and cross-reinnervation. J Physiol (1982) 0.90
Clinical and epidemiologic findings of significance to neuropharmacologic trials in OCD. Psychopharmacol Bull (1988) 0.90
Prevalence of 22q11 region deletions in patients with velopharyngeal insufficiency. Am J Med Genet (1998) 0.89
Clinical features of obsessive-compulsive disorder. Psychiatr Clin North Am (2000) 0.89
Mirtazapine augmentation in the treatment of refractory depression. J Clin Psychiatry (1999) 0.89
Sustained plasma concentrations of fluoxetine and/or norfluoxetine four and eight weeks after fluoxetine discontinuation. J Clin Psychopharmacol (1991) 0.89
Review of the putative association of dopamine D2 receptor and alcoholism: a meta-analysis. Am J Med Genet (1993) 0.89
Ventilatory work and oxygen consumption during exercise and hyperventilation. J Appl Physiol (1985) (1993) 0.89
Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia. J Pediatr (1998) 0.88
Juvenile-onset OCD: clinical features in children, adolescents and adults. Acta Psychiatr Scand (2008) 0.88
Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder. Br J Psychiatry Suppl (1989) 0.87
Selection of homogeneous populations for genetic study: the Portugal genetics of psychosis project. Am J Med Genet (1997) 0.86
Coexisting obsessive compulsive disorder and alcoholism. J Clin Psychiatry (1989) 0.86
Detection of expansion regions in Portuguese bipolar families. Am J Med Genet (2000) 0.85
Mood-related obsessive-compulsive symptoms in a patient with bipolar affective disorder. J Clin Psychiatry (1988) 0.85
Long repeat tracts at SCA8 in major psychosis. Am J Med Genet (2000) 0.84
Is resistance of a muscle to fatigue controlled by its motoneurones? Nature (1980) 0.84
Further evidence for an association between maternal smoking and craniosynostosis. Teratology (2000) 0.83
Analysis of CpG C-to-T mutations in neurofibromatosis type 1. Mutations in brief no. 129. Online. Hum Mutat (1998) 0.83
Clonidine in the treatment of Tourette's syndrome exacerbation due to haloperidol withdrawal. J Nerv Ment Dis (1986) 0.82
Association between homozygosity at the COMT gene locus and obsessive compulsive disorder. Am J Med Genet (2000) 0.82
Lithium and tryptophan augmentation in clomipramine-resistant obsessive-compulsive disorder. Am J Psychiatry (1984) 0.81
Effect of microtubular antagonists on lymphocyte mitogenesis. Nature (1977) 0.81
Gender differences in genetic linkage and association on 11p15 in obsessive-compulsive disorder families. Am J Med Genet B Neuropsychiatr Genet (2009) 0.81
Homeobox genes in obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet (2011) 0.81
Isoforms of the neuronal glutamate transporter gene, SLC1A1/EAAC1, negatively modulate glutamate uptake: relevance to obsessive-compulsive disorder. Transl Psychiatry (2013) 0.81
Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison. J Clin Psychopharmacol (1996) 0.80
Current issues in the pharmacologic management of obsessive compulsive disorder. J Clin Psychiatry (1993) 0.80
Neurologic soft signs in obsessive-compulsive disorder. Arch Gen Psychiatry (1991) 0.79
Association and linkage disequilibrium between a functional polymorphism of the dopamine-2 receptor gene and schizophrenia in a genetically homogeneous Portuguese population. Mol Psychiatry (2002) 0.79
Olanzapine prolongation of granulocytopenia after clozapine discontinuation. J Clin Psychopharmacol (2000) 0.79
A curriculum for producing resident researchers. Acad Med (1999) 0.78
Craniosynostosis and risk factors related to thyroid dysfunction. Am J Med Genet A (2015) 0.78
Neuroanatomically based approaches to obsessive-compulsive disorder. Neurosurgery and transcranial magnetic stimulation. Psychiatr Clin North Am (2000) 0.78
Sertraline in the treatment of clozapine-induced obsessive-compulsive behavior. Am J Psychiatry (1998) 0.78
Clinical features of obsessive-compulsive disorder in elderly patients. Am J Geriatr Psychiatry (1997) 0.77
Treatment of severe obsessive-compulsive disorder with fluvoxamine. Am J Psychiatry (1987) 0.77
Segregation of a familial balanced (12;10) insertion resulting in Dup(10)(q21.2q22.1) and Del(10)(q21.2q22.1) in first cousins. Am J Med Genet (1997) 0.76
The use of antibody D8/17 to identify B cells in adults with obsessive-compulsive disorder. Psychiatry Res (2001) 0.76
A time-limited behavioral group for treatment of obsessive-compulsive disorder. J Psychother Pract Res (1998) 0.76
Integrating genetic, functional genomic, and bioinformatics data in a systems biology approach to complex diseases: application to schizophrenia. Methods Mol Biol (2007) 0.76
A controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated patients with obsessive-compulsive disorder. J Clin Psychopharmacol (1991) 0.76
Motor units of the primary ankle extensor muscles of the opossum (Didelphis virginiana): functional properties and fiber types. J Morphol (1984) 0.76
Possible risperidone-induced tardive dystonia. Ann Pharmacother (2000) 0.76
Treating imagined ugliness. Arch Gen Psychiatry (1999) 0.75
Concentrations of butriptyline in biological fluids following a fatal overdose. J Anal Toxicol (1994) 0.75
Serotonin and effect sizes of antiobsessive agents. Am J Psychiatry (1992) 0.75
The natural history of obsessive-compulsive disorder. Arch Gen Psychiatry (1999) 0.75
Epidemiologic and clinical findings of significance to the design of neuropharmacologic studies of obsessive-compulsive disorder. Psychopharmacol Bull (1986) 0.75
Fluvoxamine as an antiobsessional agent. Psychopharmacol Bull (1989) 0.75